143 related articles for article (PubMed ID: 11574633)
1. Weekly 1 hour paclitaxel infusion in patients with recurrent gynecological tumors: a pilot study.
Ota S; Sugiyama T; Komai K; Hirai N; Kumagai S; Ushijima K; Nishida T; Kamura T
Jpn J Clin Oncol; 2001 Aug; 31(8):395-8. PubMed ID: 11574633
[TBL] [Abstract][Full Text] [Related]
2. Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study.
Nishio S; Ota S; Sugiyama T; Matsuo G; Kawagoe H; Kumagai S; Ushijima K; Nishida T; Kamura T
Int J Clin Oncol; 2003 Feb; 8(1):45-8. PubMed ID: 12601542
[TBL] [Abstract][Full Text] [Related]
3. [Weekly paclitaxel infusion in patients with recurrent ovarian cancer--a pilot study].
Kawagoe H; Kawata T; Nishio S; Shimomura T; Fujiyoshi K; Ishimatsu J; Tsunawaki A
Gan To Kagaku Ryoho; 2003 Jan; 30(1):151-4. PubMed ID: 12557722
[TBL] [Abstract][Full Text] [Related]
4. A feasibility study of 1-h paclitaxel infusion in patients with solid tumors.
Tsavaris N; Polyzos A; Kosmas C; Giannikos L; Gogas J
Cancer Chemother Pharmacol; 1997; 40(4):353-7. PubMed ID: 9225955
[TBL] [Abstract][Full Text] [Related]
5. Preliminary experience with salvage weekly paclitaxel in women with advanced recurrent ovarian carcinoma.
Dunder I; Berker B; Atabekoglu C; Bilgin T
Eur J Gynaecol Oncol; 2005; 26(1):79-82. PubMed ID: 15755007
[TBL] [Abstract][Full Text] [Related]
6. Salvage weekly paclitaxel in recurrent ovarian cancer.
Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
[TBL] [Abstract][Full Text] [Related]
7. Phase I and pharmacological study of single paclitaxel administered weekly for heavily pre-treated patients with epithelial ovarian cancer.
Takano M; Kikuchi Y; Kita T; Suzuki M; Ohwada M; Yamamoto T; Yamamoto K; Inoue H; Shimizu K
Anticancer Res; 2002; 22(3):1833-8. PubMed ID: 12168878
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
Kim R; Osaki A; Toge T
Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum.
Rosenberg P; Andersson H; Boman K; Ridderheim M; Sorbe B; Puistola U; Parö G
Acta Oncol; 2002; 41(5):418-24. PubMed ID: 12442916
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of weekly paclitaxel administration for patients with relapsed cervical cancer after heavy medication.
Terauchi F; Nagashima T; Kobayashi Y; Yamamoto Y; Moritake T; Seiki T; Ogura H
Gan To Kagaku Ryoho; 2005 May; 32(5):641-4. PubMed ID: 15918564
[TBL] [Abstract][Full Text] [Related]
11. Carboplatin plus paclitaxel in the treatment of gynecologic malignancies: the Cleveland Clinic experience.
Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-26-S15-29. PubMed ID: 9346218
[TBL] [Abstract][Full Text] [Related]
12. [Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer].
Uno Y; Hirano M; Murakami N; Kikuchi T; Nozawa H; Okuda T; Oya J; Kikkawa H
Gan To Kagaku Ryoho; 2002 Feb; 29(2):227-32. PubMed ID: 11865628
[TBL] [Abstract][Full Text] [Related]
13. A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
Cancer Chemother Pharmacol; 2000; 46(6):488-92. PubMed ID: 11138462
[TBL] [Abstract][Full Text] [Related]
14. Schedule- and dose-intensified paclitaxel as weekly 1-hour infusion in pretreated solid tumors: results of a phase I/II trial.
Löffler TM; Freund W; Lipke J; Hausamen TU
Semin Oncol; 1996 Dec; 23(6 Suppl 16):32-4. PubMed ID: 9007118
[TBL] [Abstract][Full Text] [Related]
15. [Weekly administration of paclitaxel for advanced or metastatic breast cancer--short-course premedications for outpatients].
Kimura M; Koida T; Yanagita Y
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1703-8. PubMed ID: 11057321
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel administered by 1-hour infusion. Preliminary results of a phase I/II trial comparing two schedules.
Hainsworth JD; Greco FA
Cancer; 1994 Aug; 74(4):1377-82. PubMed ID: 7914470
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of 3-h infusion of paclitaxel in patients with adenocarcinoma of endometrium: Japanese Multicenter Study Group.
Hirai Y; Hasumi K; Onose R; Kuramoto H; Kuzuya K; Hatae M; Ochiai K; Nozawa S; Noda K
Gynecol Oncol; 2004 Aug; 94(2):471-6. PubMed ID: 15297190
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel administered by a 1-hour infusion: A phase I-II trial comparing two schedules.
Hainsworth JD; Raefsky EL; Greco FA
Cancer J Sci Am; 1995; 1(4):281-7. PubMed ID: 9166489
[TBL] [Abstract][Full Text] [Related]
19. A feasibility study on biweekly administration of docetaxel for patients with recurrent ovarian cancer.
Oishi T; Kigawa J; Fujiwara K; Fujiwara M; Numa F; Aotani E; Katsumata N; Kohno I; Kato H; Terakawa N;
Gynecol Oncol; 2003 Aug; 90(2):421-4. PubMed ID: 12893211
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of weekly administration of paclitaxel for advanced or recurrent gastric cancer].
Egawa T; Kubota T; Nagashima A; Doi M; Kitano M; Hayashi S; Yoshii H; Saikawa Y; Kitajima M
Gan To Kagaku Ryoho; 2004 Jun; 31(6):877-81. PubMed ID: 15222104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]